Hera News & Events

­

Hera Biolabs announces Molecular Cancer Therapeutics publication on immunodeficient rats for oncology research

Hera Biolabs, the University of Michigan, Case Western Reverse University [...]

By |October 19th, 2018|

The OncoRat®: Hosting valuable tumor xenograft models that are difficult or impossible to study using in vitro or mouse models

One of the most widely used methods of modeling human [...]

By |September 18th, 2018|

Patient derived xenograft studies from wider varieties of patient sub-populations promise improved clinical trial selection and design

Around 85% of preclinical drugs entering clinical trials in oncology [...]

By |August 9th, 2018|

OncoRat® PDX models highlighted in Drug Discovery News (DDN) Special Report on Cancer: Aiming for Avatars

While advances in in-vitro platforms have allowed researchers to better [...]

By |July 18th, 2018|

Hera Biolabs to present at the 2018 AACR Annual Meeting.

Hera Biolabs will be presenting xenograft, PDX, and humanization of [...]

By |April 12th, 2018|

Understanding Transporter-Mediated Drug-Drug Interactions Using Humanized Liver Mice

Pharmaceutical researchers and regulators are increasingly aware of the influence [...]

By |January 31st, 2018|

Using Patient Derived Xenografts to Improve Therapeutic Cancer Treatments

An increased understanding of human tumors has created a solid [...]

By |January 30th, 2018|

Humanized immune-system SRG Rats™ & mice for immuno-oncology

The SRG rat demonstrates robust immune-system humanization with peripheral blood [...]

By |January 29th, 2018|

Humanized Mouse Models Advance Immunotherapeutic Strategies in Treatment of Type 1 Diabetes

A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]

By |October 17th, 2017|

Humanized Mouse Models Advance Immunotherapeutic Strategies in Treatment of Type 1 Diabetes

A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]

By |October 17th, 2017|